- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoprotein-based biomarkers as predictors for cancer therapy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 31, Pages 18401-18411
Publisher
Proceedings of the National Academy of Sciences
Online
2020-07-21
DOI
10.1073/pnas.2010103117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach
- (2018) Roberto Molinaro et al. ADVANCED MATERIALS
- Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery
- (2018) Jonathan O. Martinez et al. Theranostics
- Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
- (2018) Sena Turkdogan et al. Journal of Otolaryngology-Head & Neck Surgery
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions
- (2017) Smruthi Vijayaraghavan et al. Targeted Oncology
- B-Raf Inhibition in the Clinic: Present and Future
- (2016) Warren Fiskus et al. Annual Review of Medicine
- Effects of the protein corona on liposome–liposome and liposome–cell interactions
- (2016) Ennio Tasciotti et al. International Journal of Nanomedicine
- The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
- (2016) Claudia Corbo et al. Nanomedicine
- Biomimetic proteolipid vesicles for targeting inflamed tissues
- (2016) R. Molinaro et al. NATURE MATERIALS
- Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies
- (2016) Erika A. Newman et al. Seminars in Pediatric Surgery
- CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis
- (2016) Kangmin Zhuang et al. Cell Death & Disease
- Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
- (2016) Weiyan Xie et al. Oncotarget
- Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
- (2016) Zhenghu Chen et al. Scientific Reports
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
- (2015) Kanglai Wei et al. World Journal of Surgical Oncology
- Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis
- (2015) Karine Pozo et al. Oncotarget
- CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
- (2014) Weiyan Xie et al. International Journal of Biological Sciences
- CDK2-dependent phosphorylation of Suv39H1 is involved in control of heterochromatin replication during cell cycle progression
- (2014) Su Hyung Park et al. NUCLEIC ACIDS RESEARCH
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- The Role of Cdk5 in Neuroendocrine Thyroid Cancer
- (2013) Karine Pozo et al. CANCER CELL
- Molecular mechanisms underlying RB protein function
- (2013) Frederick A. Dick et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancer
- (2013) Steven I. Sherman ORAL ONCOLOGY
- Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor
- (2013) Hans K. Ghayee et al. PLoS One
- Histopathology of gastrointestinal neuroendocrine neoplasms
- (2013) Kenichi Hirabayashi et al. Frontiers in Oncology
- Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
- (2012) Abeba Demelash et al. MOLECULAR BIOLOGY OF THE CELL
- Deciphering the retinoblastoma protein phosphorylation code
- (2012) Seth M. Rubin TRENDS IN BIOCHEMICAL SCIENCES
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site-specifically phosphorylated forms of H1.5 and H1.2 localized at distinct regions of the nucleus are related to different processes during the cell cycle
- (2009) Heribert Talasz et al. CHROMOSOMA
- An Unusual Member of the Cdk Family: Cdk5
- (2008) Fatema A. Dhariwala et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
- (2008) R. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
- (2007) Manuel C. Lemos et al. HUMAN MUTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started